CDC reports that the 'nightmare bacteria' with the NDM gene infections rose ~ 70% from 2019–2023 & is resistant to almost all antibiotics.
At GARDP, Shionogi’s approved antibiotic cefiderocol & Bugworks’ BWC0977, now in clinical development, show activity against it.
🔗Read: bit.ly/4pFG05H
bit.ly
‘Nightmare bacteria’ cases are increasing in the U.S.
It’s likely that many people are unrecognized carriers of the drug-resistant bacteria, which could lead to community spread, CDC scientists said.